Powered by lexis nexis

CV Sciences, Inc. Announces Pre-IND Meeting Date with FDA

May 02, 2017 - Marketwired

LAS VEGAS, NV --(Marketwired - May 02, 2017) - CV Sciences, Inc. (OTCQB: CVSI) (the "Company," "CV Sciences," "our" or "we"), is pleased to announce today that it will be meeting with the U.S. Food and Drug Administration (FDA) on June 15, 2017, to discuss its initial drug candidate (CVSI-007), a chewing gum that combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco addiction.

According to the CDC, smokeless tobacco has bee...